AUG 17, 2026 · JOURNAL ARTICLE
Cardiometabolic Response to Saroglitazar in a Young Indian Man With Obesity, Prediabetes, Insulin Resistance, and High-Normal Albuminuria: A Case Report
Cureus
A single uncontrolled case report with surrogate endpoints and no comparator; the authors themselves note that modest weight change may reflect biological variation and that controlled trials are needed before clinical recommendations.
Reported
Age22 years
BMI27.6 kg/m²
Saroglitazar dose4 mg once daily